Device Trial Radar · NCT02493660
A Pivotal Study to Assess the InSpace™ Device for Treatment of Full Thickness Massive Rotator Cuff Tears
Last checked: Nov 20, 2026Latest source record: Jun 15, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
184
Actual
Start
Jun 26, 2015
Primary completion
Feb 29, 2020
Study completion Mar 17, 2020
Sponsor
- Lead sponsor
- OrthoSpace Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 9, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 40 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A pivotal study to assess the safety and effectiveness of the InSpace™ device implantation in comparison to surgical partial repair of full thickness Massive Rotator Cuff Tear (MRCT).
Conditions
- Rotator Cuff Syndrome
Interventions
InSpace sub-acromial tissue spacer systemDevice
Arthroscopic implantation of InSpace sub-acromial tissue spacer system
Partial repair of rotator cuffProcedure
Arthroscopic partial repair of rotator cuff
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants in the Per Protocol Population With Surgical Treatment Success of the InSpace Device as a Primary Surgical Treatment for Full-thickness Massive Rotator Cuff Tears From Baseline to Month 12 With no SSSIs and no SADEs.Time frame: Baseline to month 12
Locations
21 sites in 2 countries. Site status is shown where the registry gives one.
Southern California Orthopedic Institute
Van Nuys, California
University of Colorado
Denver, Colorado
Holy Cross Hospital
Fort Lauderdale, Florida
18 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.